Patent · US Active

Inhibitors of nitric oxide synthase for treatment of melanoma

US8642282B2 · kind B2 · utility

4Cited by

3References

14Claims

0Family size

Assignees

Northwestern University · US
The Regents of the University of California · US

Inventors

Frank L. Meyskens, Jr. · Irvine, US
Richard B. Silverman · Winnetka, US
Sun Yang · Lake Forest, US
Haitao Ji · Huainan City, CN
Fengtian Xue · Baton Rouge, US
Thomas L. Poulos · Irvine, US

Key dates

Filing date	Jan 12, 2012
Grant date	Feb 4, 2014
Priority date	—
Expiry date	Jan 12, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.